Drug-makers gave millions of dollars to pain-treatment advocacy groups over a five-year period beginning in 2012, in effect promoting opioids to individuals most vulnerable to addiction, a new report released Monday by a U.S. Senator says. The 23-page report , put out by Missouri Democratic Sen. Claire McCaskill, sheds light on the pharmaceutical industry's efforts to shape public opinion and to fuel demand for such lucrative and potentially addictive drugs as OxyContin, Fentanyl and Vicodin that have played a key role in the addiction crisis that has swept the U.S. in recent years, claiming hundreds of thousands of lives. Fueling an Epidemic: Exposing the Financial Ties Between Opioid Manufacturers and Third Party Advocacy Groups describes how...
READ MORE >
Drugmakers Spent Millions Promoting Opioids To Patient Groups, Senate Report Says